Commitments and Contingencies - Additional Information (Details) $ in Thousands																					1 Months Ended		2 Months Ended		3 Months Ended	6 Months Ended	11 Months Ended
	Jun. 03, 2020 USD ($)	Mar. 02, 2020 USD ($)	Jul. 31, 2019 defendant	Jun. 10, 2019 defendant	Mar. 15, 2019 defendant	Mar. 14, 2019 defendant	Feb. 15, 2019 company	Feb. 07, 2019 defendant	Jan. 23, 2019 defendant	Dec. 31, 2018 defendant	Oct. 04, 2018 defendant	Aug. 24, 2018 defendant	Jul. 18, 2018 defendant	Jul. 09, 2018 defendant	Jun. 18, 2018 request	May 30, 2018 defendant	Mar. 27, 2018 defendant	Mar. 15, 2018 defendant company	Aug. 17, 2017 company defendant	Apr. 06, 2017 complaint drug	Mar. 31, 2019 defendant	May 31, 2016 USD ($) settlement_demand	Mar. 31, 2019 defendant	Nov. 30, 2018 defendant	Jun. 30, 2020 USD ($) case	Jun. 30, 2020 USD ($) case	Apr. 30, 2015 complaint	Dec. 31, 2019 USD ($)	Nov. 01, 2019 state	May 10, 2019 state	Feb. 21, 2019 complaint	Mar. 13, 2015 Medication
Loss Contingencies [Line Items]
Number of generic medication included in antitrust division of DOJ | Medication																																4
Opana ER
Loss Contingencies [Line Items]
Number of complaints styled as class actions | complaint																											14
Texas State Attorney General Civil Investigative Demand
Loss Contingencies [Line Items]
Number of settlement demands | settlement_demand																						2
Damages sought, initial demand aggregate total																						$ 36,000
Alleged overpayments																						$ 16,000
Generic Digoxin and Doxycycline Antitrust Litigation
Loss Contingencies [Line Items]
Number of generic drugs included in consolidation of civil actions | drug																				18
Number of states, filed civil lawsuit | state																														43
Number of claims filed on behalf of additional states and territories | state																													9
Number of defendants | defendant			87
Digoxin And Lidocaine-prilocaine Litigation
Loss Contingencies [Line Items]
Number of complaints styled as class actions | complaint																				2
Number of complaints filed by opt-out plaintiffs | complaint																															2
Digoxin And Lidocaine-prilocaine Litigation | End-Payor Plaintiff
Loss Contingencies [Line Items]
Number of claims dismissed | company							7
Digoxin And Lidocaine-prilocaine Litigation | Indirect Reseller Plaintiff
Loss Contingencies [Line Items]
Number of claims dismissed | company							6
Teva Pharmaceuticals USA, Inc
Loss Contingencies [Line Items]
Damages sought, initial demand aggregate total		$ 3,860
Opiod Medications Litigation
Loss Contingencies [Line Items]
Number of defendants | defendant				20	29	31		20	18	32	45	18	41	55		4	35	51	5		39		37	37
Number of healthcare provider defendants | company																			3
Number of counties filing a complaint (more than) | company																		60
Number of cities filing a complaint | company																		12
Number of CID requests | request															11
West Virginia and Kentucky Hospitals
Loss Contingencies [Line Items]
Number of cases | case																									26	26
Number of additional cases | case																									5	5
Kathryn Eaton Vs. Teva Canada Limited
Loss Contingencies [Line Items]
Damages sought, initial demand aggregate total	$ 2,750,000
Commercial Legal Proceedings and Claims
Loss Contingencies [Line Items]
Net charge for legal proceedings																									$ 1,000	$ 6,000
Commercial and Governmental Legal Proceedings and Claims
Loss Contingencies [Line Items]
Liability related to legal proceedings																									$ 16,000	$ 16,000		$ 17,000